Flash Finance

Healthcare Global Enterprises LimitedHCGCorporate

Healthcare Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹588.20
MCap ₹8,782 Cr · P/E 264.0
Healthcare Global Enterprises Limited — Stock analysis & AI research Healthcare Global Enterprises Limited — Multibagger AI analysis Healthcare Global Enterprises Limited — Seasonality — best & worst months Healthcare Global Enterprises Limited — Technical indicators & charts Healthcare Global Enterprises Limited — Technical setup — score, trend, support & resistance Healthcare Global Enterprises Limited — Live exchange announcements
📋 Promoters Increasing Stake 📈 RSI Oversold Stocks📈 Lowest Technical Score 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹693 Cr
Sales · Jun 2026
+13.1% YoY
₹121 Cr
Operating Profit · Jun 2026
+11.8% YoY
17.4%
OPM % · Jun 2026
-1.1% YoY
₹16 Cr
Net Profit · Jun 2026
+175.3% YoY
₹0.92
EPS · Jun 2026
+187.5% YoY

📝 Healthcare Global Enterprises Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Healthcare Global Enterprises Limited reported revenue of ₹693 crore for the quarter ended June 2026 (Q1 FY27), up 13.1% from ₹613 crore in the same quarter last year, and up 6.3% sequentially over the March 2026 quarter.

Net profit rose 175.3% year-on-year to ₹16 crore, from ₹6 crore. Earnings per share (EPS) came in at ₹0.92.

Operating profit stood at ₹121 crore — an operating margin (OPM) of 17.4%, compared with 17.6% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Healthcare Global Enterprises Limited posted revenue of ₹2,545 crore, a growth of 14.6% over FY25, with a net profit of ₹23 crore (down 53.3% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,626 crore with a net profit of ₹33 crore.

Valuation snapshot

At the current price of ₹588.20, HCG has a market capitalisation of ₹8,782 crore and a trailing P/E of about 264.0.

Within the Healthcare industry, it is the 3rd-largest of the 22 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 64.21%, foreign institutional investors (FIIs) 2.69%, domestic institutional investors (DIIs) 20.77%, public shareholders 12.32% of Healthcare Global Enterprises Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹8,782 Cr
Current Price ?
₹588.2
P/E ?
264.04above ind
Industry P/E ?
34.70
P/B ?
6.59
P/S ?
3.34
P/FCF ?
148.85
Enterprise Value ?
₹10,517 Cr
EV/EBITDA ?
21.98
PEG ?
N/A
Earnings Yield ?
2.1%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹2,626 Cr
OPM ?
18.2%
Profit after tax (TTM) ?
₹33 Cr
EPS (TTM) ?
₹2.23
ROCE ?
8.0%
ROE ?
2.5%
ROA ?
0.8%
Growth
Sales — latest qtr ?
₹693 Cr
PAT — latest qtr ?
₹16 Cr
YoY qtr sales growth ?
13.1%
YoY qtr profit growth ?
175.3%
Sales growth (3y) ?
15%
Sales growth (5y) ?
20%
Profit growth (3y) ?
-1%
Profit growth (5y) ?
18%
Financial Health
Debt ?
₹1,735 Cr
Debt to Equity ?
1.30
Interest Coverage ?
1.3
Current Ratio ?
N/A
Ownership
Promoter holding ?
64.21%
Change in promoter holding ?
1.75%
Pledged percentage ?
N/A
Market
Return 3 months ?
-10.3%
Return 6 months ?
4.0%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 424441460487469464525554558585613647633652693 +13.1% +6.3%
Operating Profit 7576738578789010287106108123110125121 +11.8% -3.6%
Other Income 454375101171083-10-1815 +96.7% +180.6%
Interest 272626272924343641444544454340 -12.3% -6.6%
Depreciation 414241434444475057585863616370 +21.6% +12.1%
Profit Before Tax 1113111811151928-3141220-6125 +110.0% +1902.4%
Net Profit 4641139142187621-8416 +175.3% +307.4%
EPS 0.540.600.550.920.410.610.871.220.500.500.321.09-0.630.150.92 +187.5% +513.3%
OPM % 17.6% 17.1% 16.0% 17.4% 16.6% 16.9% 17.2% 18.5% 15.7% 18.1% 17.6% 19.1% 17.3% 19.2% 17.4% -1.1% -9.4%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹2,221 Cr ₹2,545 Cr ₹2,626 Cr +14.6%
Operating Profit ₹385 Cr ₹466 Cr ₹478 Cr +20.9%
OPM % 17.35% 18.30% 18.22% +5.5%
NPM % 2.20% 0.89% 1.27% -59.5%
Other Income ₹38 Cr ₹-18 Cr ₹-11 Cr -148.1%
Depreciation ₹211 Cr ₹244 Cr ₹257 Cr +15.5%
Interest ₹155 Cr ₹177 Cr ₹171 Cr +14.2%
EBIT ₹174 Cr ₹222 Cr ₹222 Cr +27.4%
PBT ₹57 Cr ₹27 Cr ₹40 Cr -52.7%
Tax ₹-6 Cr — ₹9 Cr —
Net Profit ₹49 Cr ₹23 Cr ₹33 Cr -53.3%
EPS ₹3.09 ₹0.93 ₹1.53 -69.9%
Material Cost ₹288 Cr — ₹187 Cr —
Employee Cost ₹175 Cr — ₹105 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 139139139149 +7.2%
Reserves 7216867831,183 +51.1%
Borrowings 9011,2741,8371,735 -5.6%
Other Liabilities 549601780855 +9.6%
Total Liabilities 2,3112,7013,5403,923 +10.8%
Fixed Assets 1,5531,7582,4422,462 +0.8%
CWIP 18832519 -24.0%
Investments 10101114 +27.3%
Other Assets 7308501,0621,428 +34.5%
Total Assets 2,3112,7013,5403,923 +10.8%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 252285317347 +9.5%
Cash from Investing Activity -133-226-488-177 +63.7%
Cash from Financing Activity -140-64-42241 +673.8%
Net Cash Flow -22-5-213410 +292.5%
Free Cash Flow 12610111059 -46.4%
CFO/OP 92%101%91%81% -11.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 65566660 -9.1%
Inventory Days 33333332 -3.0%
Days Payable 214216210185 -11.9%
Cash Conversion Cycle -116-127-111-93 +16.2%
Working Capital Days -40-70-91-61 +33.0%
ROCE % 8%9%9%8% -11.1%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 62.46%63.78%63.77%64.21%64.21% +0.0%
FIIs 2.16%3.59%3.22%2.76%2.69% -2.5%
DIIs 13.22%18.36%18.30%18.91%20.77% +9.8%
Public 22.17%14.28%14.71%14.15%12.32% -12.9%
No. of Shareholders 47,02846,97045,36647,64944,774 -6.0%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Healthcare Global Enterprises Limited's revenue in Q1 FY27?
Healthcare Global Enterprises Limited reported revenue of ₹693 crore for the quarter ended June 2026 (Q1 FY27), up 13.1% from ₹613 crore in the same quarter last year, and up 6.3% sequentially over the March 2026 quarter.
What was Healthcare Global Enterprises Limited's net profit in Q1 FY27?
Net profit rose 175.3% year-on-year to ₹16 crore, from ₹6 crore. Earnings per share (EPS) came in at ₹0.92.
What is HCG's market capitalisation and P/E ratio?
At the current price of ₹588.20, HCG has a market capitalisation of ₹8,782 crore and a trailing P/E of about 264.0.
Who owns Healthcare Global Enterprises Limited? (shareholding pattern)
As of Sep 2026, promoters held 64.21%, foreign institutional investors (FIIs) 2.69%, domestic institutional investors (DIIs) 20.77%, public shareholders 12.32% of Healthcare Global Enterprises Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI